Trials / Completed
CompletedNCT04261881
Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental & Cognitive Function and Mitochondrial Function
Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental and Cognitive Function and Improved Mitochondrial Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Natural Immune Systems Inc · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose for this protocol is to perform an open-label human clinical pilot study on the effects of consumption of two nutraceutical blends in subjects with long-term unexplained fatigue interfering with daily living.
Detailed description
This is an open-label human clinical study to evaluate the effects of consumption of the nutraceutical product ATP-Fuel, compared to the nutraceutical product ATP-II. The study participants will be randomized to one of three groups: consuming ATP-Fuel (5 capsules, twice daily); consuming ATP-II (3 capsules, once daily); or consuming ATP-II (3 capsules, twice daily). The study is of 8 weeks' duration, with evaluation at baseline, 1, 4, and 8 weeks of product consumption. At each visit the following measurements and procedures are performed: Blood pressure, questionnaires pertaining to fatigue, pain and wellness, and a blood draw. The blood is used for testing of lipid peroxidation and mitochondrial volume and metabolic activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ATP-Fuel | 5 capsules daily with breakfast and 5 capsules daily with lunch |
| DIETARY_SUPPLEMENT | ATP-II | 3 capsules daily with breakfast |
| DIETARY_SUPPLEMENT | ATP-II | 3 capsules daily with breakfast and 3 capsules daily with lunch |
Timeline
- Start date
- 2018-03-27
- Primary completion
- 2020-03-16
- Completion
- 2020-04-08
- First posted
- 2020-02-10
- Last updated
- 2020-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04261881. Inclusion in this directory is not an endorsement.